Renewal is defined as the recovery of an extinguished response when the contexts of extinction and recall differ. Prominent hippocampal activity during contextrelated extinction can predict renewal. Dopaminergic antagonism during extinction learning impaired extinction and reduced hippocampal activation, without affecting renewal. However, to what extent dopaminergic stimulation during extinction influences hippocampal processing and renewal is as yet unknown. In this fMRI study, we investigated the effects of the dopamine D2-like agonist bromocriptine upon renewal in an associative learning task, in hippocampus and ventromedial PFC. We observed significant differences between bromocriptine (BROMO) and placebo (PLAC) treatments in the subgroups showing (REN) and lacking (NoREN) renewal: the renewal level of BROMO REN was significantly higher, and associated with more prominent hippocampal activation during extinction and recall, compared to PLAC REN and BROMO NoREN. Results suggest that an interaction between D2like-agonist-induced enhancement of hippocampal activity and a preexisting tendency favoring context processing contributed to the higher renewal levels. In contrast, ventromedial prefrontal activation was unchanged, indicating that increased hippocampal context processing and not prefrontal response selection constituted the central driving force behind the high renewal levels. The findings demonstrate that hippocampal dopamine is important for encoding and providing of context information, and thus crucially involved in the renewal effect.
Introduction
The renewal effect impressively demonstrates the contextdependency of extinction learning. It is defined as the recovery of an extinguished response in cases when extinction learning has been performed in a context different from that present during recall (Bouton and Bolles, 1979) , e.g. in a so-called ABA or ABC design (Bouton, 2004) . Previously, we have shown that in a context-related associative learning task without a fear component, renewal is mediated by hippocampus and ventromedial prefrontal cortex (vmPFC) during extinction learning and recall, respectively (Lissek et al., 2013) . During extinction learning, particularly in a novel context, hippocampal activation is stronger in participants who show renewal during recall than in those who do not. Thus, hippocampal activation appears crucially involved in the encoding of context, and more effective in participants with a propensity for renewal. In addition, during extinction recall, participants with a propensity for renewal exhibit more pronounced activation in vmPFC, presumably associated with selecting the adequate response from two opposing options (Lissek et al., 2013) . These findings are in line with previous studies on fear extinction in humans which found hippocampus and vmPFC involved in context processing (Kalisch et al., 2006; Milad et al., 2007) . Moreover, hippocampal activation already during acquisition is predictive of later renewal, despite the fact that the context is still irrelevant during this phase. This finding suggests that participants with a propensity for renewal differ from those who lack renewal in their manner of context processing throughout the task, possibly by showing heightened attention to context, and/or by performing configural processing of context and cues . Therefore, individuals with and without a propensity for renewal may respond differentially to experimental manipulations that affect processing capabilities.
While the brain regions mediating renewal in humans have been investigated recently, much less is known about how various neurotransmitter systems in these regions contribute to the renewal effect. The dopaminergic system can be considered a promising candidate for modulating extinction learning and renewal, since prefrontal cortex and hippocampus are target regions for dopaminergic influences. Animal and human studies report expression of (mRNA for) D1, D2 and D3 as well as D5 receptors in PFC and hippocampus (Camps et al., 1990; Hurd et al., 2001; Khan et al., 2000; Meador-Woodruff et al., 1996; Vincent et al., 1995) . Dopamine (DA) participates in learning and attentional aspects of conditioning (El-Ghundi et al., 2007) , by directing attention to salient and novel stimuli. Furthermore it provides a teaching or reward signal during associative learning (Reynolds et al., 2001) . Accordingly, animal studies pointed out the role of DA in prefrontal regions for fear extinction (Fiorenza et al., 2012; Mueller and Cahill, 2010; Nader and LeDoux, 1999; Ponnusamy et al., 2005) . In addition, DA in hippocampus appears to be crucially involved in memory formation for novel and rewarding episodes (Shohamy and Adcock, 2010) , and has also been found to participate in fear extinction (Fiorenza et al., 2012) . The model of Lisman and Grace (2005) suggests that hippocampus and the dopaminergic neurons of the ventral tegmental area form a functional loop that regulates admittance of novel information to long-term memory. The hippocampus detects novel information and delivers a novelty signal via subiculum, accumbens and ventral pallidum to the VTA where it contributes to novelty-dependent firing, resulting in DA release in hippocampus which leads to enhanced LTP and learning. Thus, DA in hippocampus presumably has an important role for extinction learning.
However, human studies on the role of DA in extinction learning are rare. A recent behavioral study in humans showed that the dopamine precursor L-Dopa, administered after fear extinction, made extinction memory context-independent and thus reduced the return (renewal) of fear (Haaker et al., 2013) . In contrast, administration of the DA antagonist tiapride prior to context-related extinction learning impaired learning performance of healthy humans in the novel context and reduced activation in dorsolateral PFC (dlPFC), orbitofrontal PFC (OFC) and hippocampus, but did not affect renewal (Lissek et al., 2015b) . Along similar lines, a further modulation of the catecholaminergic system by the noradrenergic reuptake inhibitor Atomoxetine enhanced extinction learning and the associated prefrontal and hippocampal activation, but had no effect upon renewal either (Lissek et al., 2015a) . So while we have some evidence of the effects of a DA antagonist upon extinction learning proper and of a DA agonist upon extinction consolidation, it is as yet unknown to what extent a stimulation of the dopaminergic system during extinction learning might affect activation of these regions and the level of renewal.
In the present study, we investigated the impact of a single dose of the D2-like agonist Bromocriptine upon context-related extinction learning without a fear component and upon renewal in healthy volunteers, with a specific focus on the differences between individuals with and without a propensity for renewal. In an associative learning task, participants learned relations between cues, presented in a particular context, and outcomes, that were reversed during the extinction learning phase. This predictive learning task (Üng€ or and Lachnit, 2006) combines an ABA design suited to evoke a renewal effect with a control AAA condition that does not evoke renewal. Based on the findings from previous studies on renewal, our analyses focused on bilateral hippocampus and ventromedial PFC in a region-of-interest approach.
Based on previous findings, we assumed that DA agonism, compared with placebo, would improve extinction learning, predominantly in a novel context, regardless of participants' renewal propensity. Furthermore, we expected a concurrent increase of activation in prefrontal and hippocampal regions, reflecting improved learning and context encoding. In consequence, we predicted higher renewal levels in the D2-like agonist group compared to placebo. To account for the possibility that participants with and without a propensity for renewal might respond differently to the treatment, we compared these groups in our analyses, expecting higher renewal levels in the DA agonist group.
MATERIALS and METHODS
Participants 46 healthy volunteers without a history of neurological disorders (questionnaire, self-report) were recruited by local advertisements and randomly assigned to the treatment (BROMO) or control (PLAC) groups. After data acquisition, four subjects had to be excluded from further data analysis due to weak learning performance (<70% correct responses during acquisition), inadequate imaging datasets (bad signal or movement artifacts) or missing data. All reported analyses are calculated from the final sample of 42 participants (20 men, 22 women, mean age 25.21 years ± 3.722 st.dev, range 20-35 years). All participants had normal or corrected-to-normal vision and were right-handed (assessed by means of the Edinburgh Handedness Inventory; (Oldfield, 1971) . Participants received a monetary compensation (in the amount of 60€).
For data analyses, participants were assigned to the groups showing (REN) or not showing renewal (NOREN) based on their performance during the recall phase, in trials designed to evoke renewal (i.e. ABA trials with consequence change). All participants who never or in only a single response showed renewal (0-10% renewal responses) were assigned to the NOREN group (10% renewal was assigned to NOREN to account for a possibly erroneous response). All participants who showed a considerable percentage of renewal responses (30-100% renewal responses) were assigned to the REN group.
Ethics statement
All subjects participated in this study after giving written informed consent. The protocol was approved by the Ethics Committee of the Ruhr-University Bochum. The study conforms to the Code of Ethics of the World Medical Association (Declaration of Helsinki). Prior to the experiments, participants received handouts informing them about the fMRI procedures and the pharmacological properties and potential side effects of the DA-agonist Bromocriptine.
Predictive learning task
The predictive learning task (Üng€ or and Lachnit, 2006) that we used in this study is suited to reliably evoking a renewal effect, as was demonstrated in a number of previous studies (Lucke et al., 2013; Nelson and Callejas-Aguilera, 2007; Lachnit, 2006, 2008; Rosas and Callejas-Aguilera, 2006 ). We adapted this task for fMRI settings and already used it in previous fMRI studies (Kinner et al., 2016; Lissek et al., 2013 Lissek et al., , 2015a Lissek et al., , 2015b . In this task, participants were asked to put themselves in the position of a physician and predict whether various food items served in different restaurants would lead to the aversive consequence of a stomach ache in their patient.
During the initial acquisition phase (80 trials) participants learned to associate each presented food item with a consequence. In each trial one of eight stimuli (vegetables or fruits) was presented to the participant in one of two different contexts (indicated by the restaurant names "Zum Krug" (The Mug) and "Altes Stiftshaus" (The Dome) and a frame in either red or blue color). The stimulus in its context was first presented for 3 s, then a question asking whether the patient will develop a stomach ache was superimposed, with the response options 'Yes' or 'No'. Response time was 4 s, participants responded by pressing the respective button on an fMRI-ready keyboard (Lumitouch, Photon Control Inc. Canada). After the response, else after expiration of the response time, a feedback with the correct answer was displayed for 2 s, i.e. "The patient has a stomach ache" or "The patient does not have a stomach ache". The actual response of the participant was not commented upon. The food stimuli were presented in randomized order, each stimulus was presented ten times. Four stimuli were presented per context.
During the extinction phase (80 trials), half of the stimuli were presented in the same context as during acquisition (condition AAA -no context change -40 trials) and the other half in a different context (condition ABA -context change -40 trials) in randomized order. For actual 'extinction stimuli', the consequence of stomach ache changed and the new consequence had to be learned. For 'distractor stimuli', which were introduced in order to make overall learning more difficult, the consequence remained unchanged. Per context we used two extinction stimuli and two distractor stimuli. In all other respects, trials were identical to those during acquisition.
During the recall phase (40 trials), all stimuli were presented once again in the context of acquisition (5 presentations per stimulus). With the exception that during the recall phase no feedback with the correct response was given, trials were identical to those during acquisition.(see Fig. 2 
)
An overview of the experimental groups and the design of the predictive learning task is shown in Fig. 1 .
Procedure
Two separate fMRI sessions were performed on a single day. In a first fMRI session, participants underwent the acquisition phase of the task. Immediately afterwards, they received a single oral dose of 1.25 mg bromocriptine or an identical looking placebo. Ninety minutes after administration of the drug/placebo, in accordance with the pharmacokinetic profile of bromocriptine with peak plasma concentrations achieved around this time point (Holt et al., 2010) , the second fMRI session began, which comprised the extinction learning and extinction recall phases. Bromocriptine is a dopaminergic agonist acting on postsynaptic dopamine D2 receptors. At single doses of 1.25 mg or 2.5 mg, it has been previously used to investigate working memory, reversal learning and cognitive flexibility, demonstrating improvements of learning and memory (Cools et al., 2007 (Cools et al., , 2009 McAllister et al., 2011; Stelzel et al., 2013 ) (see Fig. 2 ).
Imaging data acquisition
Functional and structural brain scans were acquired using a wholebody 3T scanner (Philips Achieva 3.0 T X-Series, Philips, The Netherlands) with a 32-channel SENSE head coil. Blood-oxygen level dependent (BOLD) contrast images were obtained with a dynamic T2* weighted gradient echo EPI sequence using SENSE (TR 3200 ms, TE 35ms, flip angle 90 , field of view 224 mm, slice thickness 3.0 mm, voxel size 2.0 Â 2.0 Â 3.0 mm). We acquired 45 transaxial slices parallel to the anterior commissureposterior commissure (AC-PC) line which covered the whole brain. High resolution structural brain scans of each participant were acquired using an isotropic T1 TFE sequence (field of view 240 mm, slice thickness 1.0 mm, voxel size 1 Â 1x1 mm) with 220 transversally oriented slices covering the whole brain. The task was presented to the participants via fMRI-ready LCD-goggles (Visuastim Digital, Resonance Technology Inc., Northridge, CA, USA) connected to a laptop which ran specific software programmed in Matlab (Mathworks, Natick, MA, USA). Responses were given by means of an fMRI-ready keyboard (Lumitouch response pad, Photon Control Inc., Canada).
Imaging data analysis
For preprocessing and statistical analysis of fMRI data we used the software Statistical Parametric Mapping (SPM), Version 8 (Wellcome Department of Cognitive Neurology, London, UK), implemented in Matlab R2008a (Mathworks, Natick, MA, USA). Three dummy scans, during which the BOLD signal reached steady state, preceded the actual data acquisition of each session, thus preprocessing started with the first acquired volume. Preprocessing on single subject level consisted of the following steps: slice timing correction to account for time differences due to multislice image acquisition; realignment of all volumes to the first volume for motion correction; spatial normalization into standard stereotactic coordinates with 2 Â 2 Â 2 mm 3 using an EPI template of the Montreal Neurological Institute (MNI) provided by SPM, smoothing with a 6 mm full-width half-maximum (FWHM) kernel, in accordance with the standard SPM procedure. The acceptable limit for head motion was 2 mm for translational movements and 0.5 for rotational movements.
In a first level single subject analysis we calculated activation during extinction and recall phases, contrasted against baseline. We modeled regressors for the onset of each context-cue compound, question, and feedback. All regressors were modeled using distinct stick functions convolved with the canonical hemodynamic response function in the general linear model implemented in SPM, in an event-related design. Contrasts used for the second-level analyses were based on the onset of the image of the context-cue compound at the beginning of a trial, compared to baseline. The contrast images from the single subject analyses were entered into second-level random-effects analyses to compare BOLD activation in the treatment and control groups for extinction learning and recall phases in the experimental (ABA) and control (AAA) conditions.
We restricted our analyses to our a priori regions of interest, i.e. bilateral hippocampus and ventromedial prefrontal cortex. For this purpose, we created specific ROIs derived from functional data recorded in previous studies with the same predictive learning task (Lissek et al., 2013 (Lissek et al., , 2015a (Lissek et al., ,b, 2016 . From these data, we calculated the mean values of the peak coordinates of functional activation during extinction learning and recall in bilateral hippocampus and ventromedial PFC. The probabilistic hippocampal subregion location of these coordinates was identified using the SPM Anatomy Toolbox (Eickhoff et al., 2005) . Based on the results, a ROI consisting of the hippocampal cytoarchitectural subregions SUB (subicular complex), CA (cornu ammonis) and FD (fascia dentata), was used for our comparative analyses (left-hemispheric 1382 voxel, right-hemispheric 1410 voxel, bilateral 2792 voxel). For ventromedial PFC, a sphere of 25 mm diameter centered around the mean peak coordinates constituted the ROI used for our comparative analyses. (Mean peak coordinates (MNI): hippocampus: left-hemispheric -22 -30 -6, right-hemispheric 22-28 -6; ventromedial PFC: 10 48 -8). After performing a 2 Â 2 Â 2 ANOVA with repeated measures for the overall effects of treatment, renewal propensity and condition, we contrasted the activation patterns of the BROMO and PLAC/REN and NoREN groups in the phases of ABA and AAA extinction learning as well as ABA and AAA recall. In between-group analyses (two-sample t-tests for independent samples), in addition we examined the potential interaction of the independent factors treatment (BROMO or PLAC) and propensity for renewal (REN or NoREN) upon brain activation separately for the conditions of ABA and AAA extinction learning and recall, to determine to what extent the DA agonist had differential effects upon individuals with and without a propensity for renewal. For the reported results (of the second-level analyses), we applied an FWE-corrected threshold of p < .05 voxel level (initial threshold p < .001 voxel level), unless otherwise specified. 
Behavioral data analysis
For all three learning phases, log files were recorded that contained information on response latency, response type and correctness of response, from which we calculated overall error rates during acquisition and extinction learning, moreover specific error rates for distractor stimuli during extinction learning. For calculation of the renewal effect, during the recall phase only responses to stimuli with consequence change (extinction stimuli) were analyzed. The behavioral renewal effect in the predictive learning task is supposed to occur only in the condition ABA, due to the context change introduced during extinction learning. In case of renewal, associations learned during acquisition in context A will reappear in the recall phase which is again performed in context A, while extinction was performed in context B. In contrast, the AAA condition constitutes a control condition for extinction learning, since here all learning phases are performed in an identical context. If extinction learning is successful, responses during the recall phase will reflect the associations learned during extinction. Only if extinction learning is impaired, responses in the AAA recall phase will reflect associations learned during acquisition.
Errors in acquisition and extinction learning were defined as responses stating the incorrect association between the context-cuecompound and the consequence. During the recall phase, a response that referred to the association which was correct during acquisition constituted an error in the AAA condition and a renewal response in the ABA condition. Statistical analyses were performed using the IBM SPSS Statistics for Windows software package, version 23.0 (Armonk, NY: IBM Corp.). All results are quoted as mean ± s.e.m., unless stated otherwise.
For the behavioral analyses in which we compared participants who showed or did not show renewal, BROMO and PLAC participants were assigned to their respective REN subgroup if they showed at least 30% renewal responses during recall.
For a basic behavioral analysis, we performed an ANOVA with the between subjects factors treatment and renewal propensitiy and the within-subjects factors learning condition and phase. Subsequently, we calculated between-groups t-tests for independent samples comparing BROMO and PLAC/REN and NoREN groups regarding performance in acquisition, extinction learning and recall. In order to analyze the learning curve in extinction learning, we calculated an ANOVA for the complete group of participants with the between-subject factor treatment and the within-subject repeated-measures factor learning block.
Results

Overall renewal rates
In each of the two groups (BROMO n ¼ 23; PLAC n ¼ 19), nine participants, representing 39.1% of participants in the BROMO group and 47.4% of participants in the PLAC group, showed some degree of renewal. Thus, the administration of bromocriptine apparently did not affect individuals' general tendency to show renewal, per se.
Behavioral results
Overall behavioral results
An ANOVA with the between-subjects factors treatment (BROMO/ PLAC) and renewal propensity (REN/NoREN) and the within-subject factors learning condition (ABA/AAA) and learning phase (EXT/TEST) showed significant main effects of treatment (F(1) ¼ 5.809 p ¼ .021, of renewal propensity F(1) ¼ 259.176 p ¼ .000, of phase F(1) ¼ 100.015 p ¼ .000, and of condition F(1) ¼ 165.955 p ¼ .000. Moreover, it showed significant interactions of the factors included in the ANOVA: phase*treatment F(1) ¼ 5.116 p ¼ .030; phase*renewal propensity F(1) ¼ 166.930 p ¼ .000; phase*treatment*renewal propensity F(1) ¼ 7.376 p ¼ .010; condition*treatment F(1) ¼ 5.529 p ¼ .025; condition*renewal propensity F(1) ¼ 176.201 p ¼ .000; condition*treatment*renewal propensity F(1) ¼ 3.840 p ¼ .057; phase*condition F(1) ¼ 162.661 p ¼ .000; phase*condition*treatment F(1) ¼ 7.492 p ¼ .009; phase*condition*renewal propensity F(1) ¼ 163.769 p ¼ .000; phase*condition*treatment*renewal propensity F(1) ¼ 4.647 p ¼ .038; treatment*renewal propensity F(1) ¼ 5.765 p ¼ .021. Based on these findings, we further analyzed the specific effects of interest.
Effects of the D2-like agonist bromocriptine upon learning performance -REN/NoREN
We observed no significant performance differences between groups showing renewal during acquisition of the predictive learning task (t(16) ¼ .512 p ¼ .615; mean percent errors ± s.e.m.: BROMO REN 13.75% ±2.85; PLAC REN 11.94% ±2.06). In participants who showed no renewal, there were no significant group differences either during acquisition (t(22) ¼ -1.420 p ¼ .170; mean percent errors ± s.e.m.: BROMO NoREN 10.54% ±1.29; PLAC NoREN 14.62% ±2.91). The results indicate that prior to drug administration, the learning capacities of the groups did not differ.
During extinction, the administration of bromocriptine did not significantly affect learning performance in either subgroup, compared to placebo, even though the error rate of BROMO REN during ABA extinction was considerably lower than in PLAC REN (ABA extinction BROMO vs PLAC: REN groups t(16) ¼ -1.465 p ¼ .162; NoREN groups t(22) ¼ .285 p ¼ .779; AAA extinction BROMO vs PLAC: REN groups t(16) ¼ -.207 p ¼ 838; NoREN groups t(22) ¼ .599 p ¼ .555 (mean error rates: see Table 1 below and Fig. 3) .
Learning progress during extinction learning
In order to further evaluate the groups' learning progress, we subdivided the extinction session into eight blocks with 10 trials each and calculated the percentage of extinction errors in ABA and AAA for each of these blocks. For further analyses we grouped the blocks into three phases which previously proved to reflect distinct phases of extinction learning (Lissek et al., 2015a; Lissek et al., 2015b) : initial exposure to changed stimulus-outcome contingencies (1st block), early extinction learning (blocks 2-5) and late extinction learning (blocks 6-8).
A comparison of only REN participants of the BROMO and PLAC groups in ABA extinction learning by means of an ANOVA with the repeated measures factor learning phase yielded a significant interaction of treatment and learning phase (F(2) ¼ 4.655 p ¼ .017) as well as significant main effects for treatment (F(1) ¼ 6.055 p ¼ .026) and learning phase (F(2) ¼ 16.448 p ¼ .000). Post-hoc t-tests showed a significant group difference in error rates during the initial exposure to the extinction trials in the 1st extinction block (t(16) ¼ 2.630 p ¼ .009 one-tailed), with the BROMO REN group committing significantly fewer errors (BROMO REN 15.56% ±5.55, PLAC REN 40% ±7.45). There were no significant differences in the early and late extinction learning phases. For AAA extinction learning, in contrast, the ANOVA with repeated measures showed no significant main effect of treatment and no significant interaction, while the main effect of learning phase was significant (F(2) ¼ 26.533 p ¼ .000).
The comparison of BROMO and PLAC NoREN groups by means of ANOVA with the repeated measures factor learning phase did not yield significant main effects of treatment nor significant interactions, while the main effect of learning phase remained significant for ABA and AAA extinction learning (ABA extinction: F(2) ¼ 28.652 p ¼ .000; AAA extinction: F(2) ¼ 26.015 p ¼ .000).
Effects of the D2-like agonist bromocriptine upon extinction recall -REN/ NoREN
In ABA recall, i.e. in the condition designed to evoke renewal, we observed a significantly higher renewal rate in BROM REN participants, compared with PLAC REN (t(16) ¼ 2.250 p ¼ .039 two-tailed, mean percentage of renewal responses BROM REN 86.66% ±4.08, PLAC REN 61.11% ±10.59) (see Fig. 3 ). In the control condition, AAA recall, groups did not differ significantly in their percentage of renewal responses (t(16) ¼ .000 p ¼ 1.00; BROM REN 2.22% ±2.22, PLAC REN 2.22% ±2.22), indicating that BROMO REN participants' pronounced ABA renewal behavior was not caused by impaired recall of associations learned during extinction. In the participants belonging to the NoREN groups, there were no significant differences in ABA or AAA recall (ABA recall: t(22) ¼ .840 p ¼ .410, BROMO NoREN 0.71% ±0.71, PLAC NoREN 0.0% ±0.0; AAA recall: t(22) ¼ -1.791 p ¼ .087, BROMO NoREN 0.0% ±0.0, PLAC NoREN 2.0% ±1.33%).
As expected, we observed no significant performance differences between early and late trials in the ABA recall phase -renewal rates in were evenly distributed across these trials: trials (t-test for matched samples: BROMO t(8) ¼ -1.000 p ¼ .347; early 84.44% ( ±4.44), late 88.89%( ±4.84); PLAC t(8) ¼ -1.250 p ¼ .247; early 55.56% ±13.24 late 66.67% ±9.42).
Correlation between ABA extinction performance and recall
Across REN groups, we observed a significant negative correlation between errors in ABA extinction learning and renewal rates: r ¼ À.564, n ¼ 18, p ¼ .015 (two-tailed), indicating that participants with fewer extinction errors tended to show a higher percentage of renewal.
Imaging results
In our imaging analyses we focused upon activation in ventromedial prefrontal and hippocampal regions, areas which crucially contribute to context processing and renewal, in order to analyze whether dopaminergic D2-like processes in these regions have differential effects in participants with and without a propensity to show renewal.
Overall effects of treatment, renewal propensity and task condition upon hippocampal activation during extinction learning and recall
In an 2 Â 2 Â 2 ANOVA with the within-subject factor condition (ABA/AAA) and the between-subject factors treatment (BROMO/PLAC) and renewal propensity (REN/NoREN), we evaluated the overall effects of these factors upon activation in hippocampus and ventromedial PFC. The results revealed a main effect of treatment and renewal propensity and an interaction between treatment and renewal propensity in bilateral hippocampus. The within-subject factor condition yielded no significant main effects upon hippocampal activation.
During extinction recall, no main effects and interactions survived the threshold level of SVC FWE-corrected p < .05 voxel level (see Table 2 ).
Overall effects of treatment, renewal propensity and task condition upon ventromedial PFC activation during extinction learning and recall
In ventromedial PFC, no significant main effects of treatment, renewal propensity or condition or interactions of treatment and renewal were observed.
Proceeding from these overall findings, we specifically investigated the effects of bromocriptine upon participants with a propensity for renewal, comparing BROMO REN and PLAC REN participants as well as BROMO REN and NoREN participants.
BROMO REN vs PLAC REN
During extinction learning, we observed significant differences in medial temporal lobe activation between the experimental and control subgroups of participants who later showed renewal (REN) in the contrast BROMO REN > PLAC REN. Compared to participants receiving placebo (PLAC REN), participants who had received the D2-like agonist Bromocriptine (BROMO REN) exhibited higher BOLD activation in bilateral hippocampus (MNI coordinates -26 -28 -10 and 36 -16 -24; see Table 3 and Fig. 4) . During extinction recall, BROMO REN participants showed higher activation in left hemispheric hippocampus (MNI coordinates -32 -28 -12; see Table 3 and Fig. 4) .
No regions in hippocampus showed increased BOLD activation in the opposite contrast, PLAC REN > BROMO REN.
In an additional analysis differentiating between conditions, BROMO REN showed higher activation than PLAC REN in lefthemispheric hippocampus during ABA (MNI coordinates -20 -10 -16, 52 voxel; -26 -32 -12, 201 voxel) and AAA extinction (-28 -28 -19, 144 voxel p < .08 FWEcorrected). In recall, groups did not differ significantly.
Activation in ventromedial PFC and other prefrontal regions
None of the activations observed in vmPFC regions during extinction and recall in the contrasts of BROMO REN and PLAC REN groups survived FWE correction.
Correlation between hippocampal activation during extinction learning and renewal rates
In a one-sample t-test, we identified activation in bilateral hippocampal regions during ABA extinction learning common to all participants, and calculated correlations of the mean signal intensities of these activations with later renewal performance.
Across the BROMO group, bilateral hippocampus activation during ABA extinction learning was positively correlated with later renewal performance (left hippocampus r ¼ .521 p ¼ .011, peak coordinate -22 -26 -8; right hippocampus r ¼ .413 p ¼ .049, peak coordinate 18-30 -6). In the PLAC group, hippocampal activation during ABA extinction did not correlate with later renewal rates.
BROMO REN vs NoREN
In a comparison of the REN and NoREN subgroups that had received Bromocriptine, we observed higher activation in BROMO REN participants during extinction learning (ABA and AAA conditions) in lefthemispheric hippocampus. During extinction recall, no differences between the groups were found (see Table 4 and Fig. 5 ). 
Activation in ventromedial PFC
We observed no activation differences between BROMO REN and NoREN participants in prefrontal regions, neither during extinction learning nor during recall.
BROMO NoREN vs PLAC NoREN
In contrast to the previous findings, the NoREN group that had received Bromocriptine showed reduced right-hemispheric hippocampal activation during extinction learning compared to the PLAC NoREN group. During extinction recall, no differences were observed (see Table 5 ).
BROMO > PLAC & REN > NoREN
To consider the combined effects of dopaminergic stimulation and a propensity for renewal upon hippocampal activation, we performed an analysis contrasting the treatment groups and the subgroups showing or not showing renewal. During extinction learning in both conditions ABA and AAA, regions in bilateral hippocampus responded differentially to the administration of the DA agonist depending on the participants' propensity to show renewal (see Table 6 and Fig. 6 ).
Probabilistic localization of hippocampal BOLD activation differences
Using the SPM Anatomy toolbox, we checked the activated clusters resulting from the above analyses for their probability of belonging to a particular subregion of hippocampus. Based on the results from the calculation of the cytoarchitectonic probabilities for the peak voxels, hippocampal activation differences between REN participants of the BROMO and PLAC groups were located predominantly in bilateral dentate gyrus (MNI coordinates -26 -28 -10; -32 -28 -12) and CA 1 and 3 (MNI coordinates 36 -16 -24; -32 -28 -12) . Also differences between NoREN participants of these groups were located in lefthemispheric dentate gyrus and CA 1 . The interaction between treatment and renewal propensity appeared to be predominantly located in lefthemispheric subiculum , while the main effect of treatment was located in bilateral CA1 (MNI coordinates -34 -36 -10, 30 -12 -24) and righthemispheric dentate gyrus (MNI coordinates 20 -12 -24).
Discussion
In this study on the effects of dopaminergic stimulation upon extinction learning and renewal, we specifically focused on potential differences in learning performance, as well as hippocampal and prefrontal activation between participants with and without a propensity for renewal. The main findings were: Fig. 4 . Differences in hippocampal activation between BROMO REN and PLAC REN participants, p < .05 FWE-corrected: BROMO REN participants show more pronounced activation than PLAC REN in bilateral hippocampus during extinction (peak MNI coordinates 36 -16 -24 and -26 -28 -10) and in left-hemispheric hippocampus during recall (peak MNI coordinates -32 -28 -12). The bar graph represents the parameter estimates for the BROMO and PLAC REN subgroups regarding hippocampal activation in the various task phases. Participants who received bromocriptine and showed renewal exhibited enhanced hippocampal BOLD activation during extinction learning and recall, associated with increased renewal levels.
In contrast, bromocriptine did not modulate prefrontal activation, regardless of participants' propensity for renewal. Correspondingly, error rates during extinction learning remained largely unchanged by administration of the D2-like agonist.
The D2-like agonist bromocriptine selectively strengthens hippocampal activation during extinction learning and recall in those participants who show renewal, and increases their level of renewal During extinction learning in the ABA and AAA conditions, BOLD activation in hippocampal regions of the BROMO REN group was significantly increased, both relative to the PLAC REN group and the BROMO NoREN group. Also during extinction recall, hippocampal activity was higher in BROMO REN compared to PLAC REN, but not increased relative to BROMO NoREN. In a combined analysis, regions in bilateral hippocampus showed an interaction of treatment and tendency for renewal during ABA extinction learning, as well as in left hippocampus during AAA extinction, demonstrating higher BOLD activation in those BROMO participants who subsequently showed renewal.
Consequently, the prominent hippocampal engagement in the BROMO REN group during extinction learning most likely reflects an interaction between these individuals' inherent context processing predisposition, which requires hippocampal recruitment, and the experimental stimulation of dopaminergic processing.
While an identical number of participants (n ¼ 9) in the experimental and control groups exhibited some degree of renewal, the BROMO REN group showed a significantly higher overall level of renewal responses, compared to PLAC REN, reflecting the BROMO REN group members' stronger tendency to consider the context in their responses. With 61.66% renewal responses, the PLAC REN group's level was roughly comparable to that observed in previous studies in experimental and placebo groups (see Lissek et al., 2013 Lissek et al., , 2015a , while the BROMO REN group's renewal level was particularly high (86.66%), compared to our previous studies.
It has been suggested that during extinction, the surprising, unexpected change in the contingency between stimulus and outcome will induce organisms to attend to and encode the context (Darby and Pearce, 1995) . This context encoding again will reflect in renewal during recall. Following this line of argumentation, more extinction errors might be associated with more surprise and thus more attention to context, which in consequence might yield more renewal in recall. However, our present findings indicate that in the complete sample, extinction error rates were unrelated to later renewal. Of note, in participants who showed renewal, extinction error rates were even negatively correlated with renewal -the more errors participants made, the lower their number of renewal responses. Therefore, while attention to context may be triggered by surprise at unexpected changes in outcome, a few instances of such surprises appear to be sufficient to induce context encoding.
Correspondingly, hippocampal BOLD activation in BROMO participants during extinction was found positively correlated with renewal rates, a finding which underlines the important link between hippocampus-mediated context encoding and renewal. In addition, the parallel increase of hippocampal activity and renewal rates induced by the D2-like agonist shows that hippocampal dopamine plays an important role in the phenomenon of renewal.
Our findings complement the study by Haaker and colleagues (Haaker et al., 2013) , who found a reduction of (fear) renewal following administration of L-Dopa after fear extinction learning. While the time point of dopaminergic stimulation (affecting extinction learning proper or its consolidation) appears to be crucial for determining the result with regard to renewal, these studies still deliver converging evidence that the dopaminergic system participates in processes that mediate renewal.
Moreover, the present results support the idea that hippocampal activity in the subsequent phases of extinction and recall has different roles for renewal. Pronounced hippocampal recruitment during extinction learning, reflecting context encoding, appears to be a prerequisite for successful context retrieval in recall: the differences in hippocampal extinction activity between BROMO REN and NoREN groups indicate that the former performs context encoding while the latter does not; on the other hand, the differences in hippocampal extinction activity between BROMO and PLAC REN are mirrored in their renewal rates. However, the impact of hippocampal BOLD activation during recall appears to be dependent on hippocampus performance during extinction: BROMO REN participants showed more prominent BOLD activation in hippocampus than PLAC REN, but exhibited no difference compared to BROMO NoREN. These findings suggest that high hippocampal BOLD activation during recall may promote context retrieval and have a role for renewal, but only if it can draw on the results of efficient context encoding during extinction. Together, these findings strongly support the assumption that hippocampal BOLD activation during extinction learning, reflecting context encoding, plays a more important role for later renewal (Lissek et al., 2013) than hippocampal activation during recall.
In summary, the results indicate that in our study, dopaminergic stimulation predominantly affected context processing in hippocampus during extinction and recall. Actually, D2 receptors, the targets of the D2like agonist bromocriptine we administered, appear to be involved in hippocampal processing: D2 receptors in hippocampus were found to importantly contribute to hippocampal functions such as long-term memory as well as to modulate frontal lobe functions (Takahashi et al., 2007 (Takahashi et al., , 2008 . Along these lines, in our study better context encoding during extinction learning presumably supported better context retrieval in recall, resulting in improved differentiation of contexts which -in predisposed individuals -enabled high rates of renewal.
Dopaminergic stimulation by bromocriptine does not affect overall extinction learning performance and ventromedial prefrontal activation
Contrary to our initial hypothesis, the D2-like agonist bromocriptine did not enhance overall learning performance during the extinction session, compared to placebo. However, the subgroup of BROMO REN participants showed a slight, albeit statistically non-significant advantage in overall ABA extinction learning, with lower error rates, compared to PLAC REN. This slight learning advantage manifested itself in particular during the initial exposure to changed stimulus-outcome contingencies (1st extinction block), where BROMO REN participants made significantly less errors than PLAC REN, suggesting a very quick adaptation of responding to changed contingencies of stimuli presented in a novel context. For condition AAA, no such differences were observed, neither in the complete groups nor in the subgroups of REN participants. So while we cannot observe an overall enhancement of extinction learning attributable to the D2-like agonist, bromocriptine nevertheless produced a selective processing enhancement during initial extinction in a novel context (ABA), only in participants who have a propensity for renewal. The present results are complementary to those found previously with the same study design: administration of the DA antagonist tiapride caused a selective impairment in extinction learning in a novel context (condition ABA) (Lissek et al., 2015b) , without affecting extinction learning in the identical context (AAA). Together, these findings suggest that dopaminergic processing is importantly involved in acquiring a novel configuration of context, stimulus and outcome, but not so much in the de-and re-coupling of a context-stimulus-compound from its previous outcome to a novel one.
In parallel to the failure to profoundly modulate ABA extinction learning, bromocriptine also failed to modulate prefrontal processing: Ventromedial prefrontal activation in BROMO REN and NoREN remained unchanged during extinction and recall, relative to PLAC REN and NoREN, indicating no enhancing effects of bromocriptine upon prefrontal dopaminergic processing. BROMO REN and NoREN participants did not differ either in their levels of prefrontal activation, suggesting that in this region no interaction between response tendency and dopaminergic stimulation occurred. Thus, the lack of an extinction learning enhancement in BROMO participants may be related to a differential effect of the DA agonist upon hippocampal and prefrontal regions. As a selective D2 receptor agonist, bromocriptine may indeed have differential effects upon prefrontal and hippocampal processing. While hippocampal D2 but not D1 receptors were found to contribute to hippocampus-mediated long-term memory and to modulation of frontal lobe functions, as mentioned above, conversely, D1 but not D2 receptors in prefrontal cortex participated in executive functioning in the Wisconsin Card Sorting Test (Takahashi et al., 2007 (Takahashi et al., , 2008 . This preferential recruitment of different DA receptor types may partially explain why effects of bromocriptine can differ depending on task type and involved brain regions: At doses of 1.25 mg, as used in our study, bromocriptine improved working memory in healthy participants (McAllister et al., 2011) , but reduced accuracy in delayed matching-to-sample tasks, together with decreasing activation in various task-related regions (Gibbs and D'Esposito, 2005) . Comparable to our results, this study observed differential effects of bromocriptine upon various brain regions, ranging from activation increases to decreases, or unchanged activation. Along similar lines, a study by Stelzel and colleagues (Stelzel et al., 2013) found no improvement of performance after bromocriptine administration in a switching task, together with largely reduced or unchanged activation in participating brain regions.
Consequently, the lack of prefrontal modulation by the DA agonist appears to be related to the lack of an effect upon extinction learning performance, a finding which complements the results from the study using the DA antagonist tiapride (Lissek et al., 2015b) . In that study, deactivation in prefrontal regions occurred during extinction learning, while a negative correlation between BOLD signal intensity in dlPFC and OFC and extinction learning performance in the ABA condition indicated that higher activation in these areas was associated with less errors. Together, these results underline the important role of dopaminergic processing in prefrontal regions for extinction learning in a novel context.
To sum up, however, the vmPFC, which was previously found importantly activated during extinction recall in REN participants (Lissek et al., 2013 (Lissek et al., , 2015b (Lissek et al., , 2015a , engaging in retrieval and response selection, here displayed no differential activation in experimental and control groups. Therefore, prefrontal response selection processes presumably were not influenced by the D2-like agonist, which in turn supports the above described assumption that the observed high renewal levels were crucially driven by hippocampal activity primarily during extinction learning, and only to a lesser extent during recall.
Divergent effects of the D2-like agonist upon hippocampal activation in participants with and without renewal, compared to placebo Of note, the D2-like agonist exerted opposing effects upon activation in hippocampus in REN and NoREN participants, relative to their respective control groups. While during extinction learning and recall, the NoREN participants of the experimental and control group did not exhibit any differences in learning performance, hippocampal activation was slightly reduced in the BROMO NoREN group compared to the PLAC NoREN group during extinction learning in both conditions. Since the NoREN participants showed no learning deficits relative to the REN participants either, these findings suggest that dopaminergic hippocampal processing is not indispensable for a mode of task processing that disregards context information while associating a stimulus with an outcome.
Potential effects of bromocriptine upon 5-HT receptors
Serotonin and dopamine interact in memory formation and learning (Gonzalez-Burgos and Feria-Velasco, 2008; Olvera-Cortes et al., 2008) due to the dense serotonergic innervation of brain regions involved in cognition, e.g. prefrontal cortex and hippocampus. 5HT1A receptors in hippocampus play a role in spatial learning memory (Glikmann-Johnston et al., 2015) , with potential laterality effects in avoidance learning (Belcheva et al., 2007) . Infusion of a 5HT1A receptor agonist into prelimbic cortex altered contextual fear conditioning behavior in rats (Almada et al., 2015) , while infusions into dorsal hippocampus had no effects (Almada et al., 2013) . Systemic administration of the 5HT1A receptor agonist tandospirone facilitated fear extinction learning in rats, an effect supposed to rely on dopaminergic modulation (Saito et al., 2013) . The 5-HT1A/7 receptor agonist 8-OH-DPAT facilitatated memory consolidation of an autoshaping task (Manuel-Apolinar and Meneses, 2004) . A PET study in humans identified an inhibitory effect of 5-HT1A receptors in hippocampus on human explicit memory, indicated by a negative correlation between receptor binding and memory performance (Yasuno et al., 2003) . Also in ventral prefrontal cortex, both serotonergic and dopaminergic neurotransmitter systems can modulate reversal learning and decision making processes (Clark et al., 2004) . Serotonergic modulation by means of tryptophan depletion of human dorsomedial, but not ventrolateral PFC was observed in a reversal task (Evers et al., 2005) .
Bromocriptine, while a potent D2-like agonist, also has the potential to act as a 5-HT agonist, even though, to our best knowledge, there are no studies on learning and memory in humans and animals that used bromocriptine as a 5HT-receptor agonist. Instead, a number of studies that compared effects of agonists upon the dopaminergic and serotonergic system in healthy volunteers used bromocriptine as a DA agonist contrasted against 5-HT agonists such as fenfluramine or other drugs (e.g. flesinoxan, CGS 12066B) (Gerra et al., 2000; Haney et al., 2001; Luciana et al., 1998; Monti and Jantos, 2008) . For example, a study in humans that evaluated the roles of dopamine and serotonin in human spatial working memory even found opposing functions -bromocriptine as a DA agonist facilitated delayed but not immediate memory, fenfluramine as a 5HT agonist impaired delayed memory, but had no effect upon immediate memory (Luciana et al., 1998) .
Thus in research on learning and memory, bromocriptine is generally used as a DA agonist whose effects upon the serotonergic system appear to be considered negligible. Still, in our study a partial effect of bromocriptine upon the serotonergic system in hippocampus and prefrontal cortex cannot be completely ruled out, and so might have contributed to the observed results.
Conclusion
The present results demonstrate for the first time that dopaminergic D2 receptor stimulation prior to extinction learning can induce a selective strengthening of behavioral and neural correlates of renewal, which occurs only in individuals who have an inherent tendency to consider the context in extinction learning.
The significantly higher activation in hippocampus during extinction learning in bromocriptine-treated individuals who showed renewal, compared to those who did not, indicates an interactive effect of dopaminergic stimulation and pre-existing processing tendencies upon hippocampal recruitment, which in turn led to increased renewal levels during recall. Moreover, prefrontal activation during extinction learning and recall did not differ significantly between individuals who showed renewal, regardless of treatment -a finding that suggests that the higher renewal levels in the DA agonist group were mediated predominantly by their increased hippocampal activation, which reflects context encoding during extinction and retrieval during recall.
In summary, our findings provide new insight into the neural mechanisms of renewal, pointing out the prominent role of dopamine in hippocampus for context encoding and retrieval, which supports behavioral flexibility in extinction learning and response selection in recall.
